PLEASE NOTE: Legislative Information cannot perform research, provide legal advice, or interpret Maine law. For legal assistance, please contact a qualified attorney.
An Act To Amend the Laws Governing Access to Prescription Monitoring Information
Be it enacted by the People of the State of Maine as follows:
Sec. 1. 22 MRSA §7250, sub-§4, ¶K, as amended by PL 2017, c. 213, §6, is further amended to read:
 
K. The chief medical officer, medical director or other administrative prescriber employed by a licensed hospital, insofar as the information relates to prescriptions written by prescribers employed by that licensed hospital; and
Sec. 2. 22 MRSA §7250, sub-§4, ¶L, as enacted by PL 2017, c. 213, §7, is amended to read:
 
L. Staff members of a group practice of prescribers who are authorized by a designated group practice leader, insofar as the information relates to a patient receiving care from that group practice.;
Sec. 3.  22 MRSA §7250, sub-§4, ¶M  is enacted to read:
 
M.  The United States Attorney for the District of Maine in connection with an authorized criminal investigation pursuant to a valid court order that is based upon a finding of good cause and that imposes appropriate safeguards against unauthorized disclosure; and
Sec. 4.  22 MRSA §7250, sub-§4, ¶N  is enacted to read:
 
N.  The Attorney General pursuant to Title 5, section 211.
 
SUMMARY
This bill expands the list of persons that may access prescription monitoring information to include the United States Attorney for the District of Maine in specified instances and the Attorney General under the laws governing unfair trade practices.